Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer. (Q43250802)
Jump to navigation
Jump to search
scientific article published on 31 October 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer. |
scientific article published on 31 October 2009 |
Statements
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer (English)
Trine Zeeberg Buch-Hansen
Lise Bentzen
Morten Hoeyer
Niels Viggo Jensen
Charlotte Saxe
31 October 2009